Skip to main content
Premium Trial:

Request an Annual Quote

Genizon BioSciences Adopts Illumina s BeadChips for Disease-Association Research

NEW YORK, Jan. 12 (GenomeWeb News) - Genizon BioSciences will use Illumina's whole-genome genotyping platform for its disease-association research program, Illumina said today.


Genizon will conduct whole genome-association studies on at least 16,000 case and control samples in 11 common diseases over the next year and a half, Illumina said. Genizon has completed three such studies.


DNA samples will be collected in collaboration with over 900 clinical investigators in Quebec. Genizon will use a custom version of Illumina's Sentrix HumanHap300 BeadChip, tailored to genetic sharing in the Quebec population, to query over 350,000 SNP loci per sample.


Genizon will expand its existing Illumina system with six additional BeadArray Readers, extensive automation, LIMS to integrate workflows, and new BeadStudio software.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.